medroxyprogesterone acetate has been researched along with Testicular Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, V; Loveland, KL; Manuelpillai, U; McLachlan, R; Meachem, S; Rajpert-De Meyts, E | 1 |
| Cavalli, F; Hansen, H; Klepp, O; Rozencweig, M | 1 |
| Fosså, SD; Klepp, O; Norman, N | 1 |
3 other study(ies) available for medroxyprogesterone acetate and Testicular Neoplasms
| Article | Year |
|---|---|
Activin receptor subunits in normal and dysfunctional adult human testis.
Topics: Activin Receptors; Adolescent; Adult; Carcinoma in Situ; Drug Synergism; Gonadotropins; Humans; Immunohistochemistry; In Situ Hybridization; Male; Medroxyprogesterone Acetate; Protein Isoforms; RNA, Messenger; Seminoma; Sertoli Cells; Spermatocytes; Spermatogonia; Testicular Neoplasms; Testis; Testosterone; Tissue Distribution | 2008 |
Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents; Drug Evaluation; Dysgerminoma; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1983 |
Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Spermatogenesis; Spermatogenesis-Blocking Agents; Testicular Neoplasms; Testosterone | 1988 |